Skip to content
10-K

Annual Report

FRAZIER LIFESCIENCES ACQUISITION CORPORATION

0001193125-22-085304

← back to feed
Filed
Mar 25, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2021 · Dec 31, 2021 −$138.38K
Cash And Equivalents FY 2021 · Dec 31, 2021 $1.23M
Stockholders Equity FY 2021 · Dec 31, 2021 −$6.36M
Current Liabilities FY 2021 · Dec 31, 2021 $222.07K
Total Liabilities FY 2021 · Dec 31, 2021 $7.86M
Current Assets FY 2021 · Dec 31, 2021 $1.49M
Total Assets FY 2021 · Dec 31, 2021 $139.51M
Sga Expense FY 2021 · Dec 31, 2021 $1.25M
Net Income FY 2021 · Dec 31, 2021 $4.18M
Operating Income FY 2021 · Dec 31, 2021 −$1.37M